Abstract: Certain aspects of the present disclosure provide techniques for providing sentiment analysis of content. In order to determine the overall sentiment of content, a request is received by a sentiment analyzer, which then identifies a content identification number and retrieves comments associated with the content identification number. The sentiment analyzer pre-processes the comments, which includes removing all personal identifying information from the comments. The sentiment analyzer sends the pre-processed comments to a natural language processing service, and in turn, receives sentiment indications corresponding to the comments provided. Based on the sentiment scores, the sentiment analyzer generates a sentiment analysis and displays the sentiment analysis in the graphical user interface generated by the sentiment analyzer.

Abstract: Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein. Methods of treating cancer, cardiovascular disease, cardiac failure, diabetes, Alzheimer's disease, Parkinson's disease and other brain diseases, fatty liver disease, obesity, cataracts, osteoporosis, muscle wasting, sleep disorders, acoustic trauma, inflammatory disease, psoriasis, arthritis, colitis, aging, viral disease, reproductive disease, and skin conditions or disorders including administering a therapeutically effective amount of the compositions to a subject in need are also provided. The compositions may be topically applied to skin or mucous membranes.

Abstract: The disclosure herein generally relates to the field of autonomous navigation, and, more particularly, to a diverse trajectory proposal for autonomous navigation. The embodiment discloses a hierarchical network based diverse trajectory proposal for autonomous navigation. The hierarchical 2-stage neural network architecture maps the perceived surroundings to diverse trajectories in the form of trajectory waypoints, that an autonomous navigation system can choose to navigate/traverse. The first stage of the disclosed hierarchical 2-stage Neural Network architecture is a Trajectory Proposal Network which generates a set of diverse traversable regions in an environment which can be occupied by the autonomous navigation system in the future. The second stage is a Trajectory Sampling network which predicts a fine-grained trajectory/trajectory waypoint over the diverse traversable regions proposed by Trajectory Proposal Network.

Abstract: Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein. Methods of treating cancer, cardiovascular disease, cardiac failure, diabetes, Alzheimer's disease, Parkinson's disease and other brain diseases, fatty liver disease, obesity, cataracts, osteoporosis, muscle wasting, sleep disorders, acoustic trauma, inflammatory disease, psoriasis, arthritis, colitis, aging, viral disease, reproductive disease, and skin conditions or disorders including administering a therapeutically effective amount of the compositions to a subject in need are also provided. The compositions may be topically applied to skin or mucous membranes.

Abstract: Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein. Methods of treating cancer, cardiovascular disease, cardiac failure, diabetes, Alzheimer's disease, Parkinson's disease and other brain diseases, fatty liver disease, obesity, cataracts, osteoporosis, muscle wasting, sleep disorders, acoustic trauma, inflammatory disease, psoriasis, arthritis, colitis, aging, viral disease, reproductive disease, and skin conditions or disorders including administering a therapeutically effective amount of the compositions to a subject in need are also provided. The compositions may be topically applied to skin or mucous membranes.

Abstract: The disclosure herein generally relates to the field of autonomous navigation, and, more particularly, to a diverse trajectory proposal for autonomous navigation. The embodiment discloses a hierarchical network based diverse trajectory proposal for autonomous navigation. The hierarchical 2-stage neural network architecture maps the perceived surroundings to diverse trajectories in the form of trajectory waypoints, that an autonomous navigation system can choose to navigate/traverse. The first stage of the disclosed hierarchical 2-stage Neural Network architecture is a Trajectory Proposal Network which generates a set of diverse traversable regions in an environment which can be occupied by the autonomous navigation system in the future. The second stage is a Trajectory Sampling network which predicts a fine-grained trajectory/trajectory waypoint over the diverse traversable regions proposed by Trajectory Proposal Network.

Abstract: Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein. Methods of treating cancer, cardiovascular disease, cardiac failure, diabetes, Alzheimer's disease, Parkinson's disease and other brain diseases, fatty liver disease, obesity, cataracts, osteoporosis, muscle wasting, sleep disorders, acoustic trauma, inflammatory disease, psoriasis, arthritis, colitis, aging, viral disease, reproductive disease, and skin conditions or disorders including administering a therapeutically effective amount of the compositions to a subject in need are also provided. The compositions may be topically applied to skin or mucous membranes.

Abstract: Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein. Methods of treating cancer, cardiovascular disease, cardiac failure, diabetes, Alzheimer's disease, Parkinson's disease and other brain diseases, fatty liver disease, obesity, cataracts, osteoporosis, muscle wasting, sleep disorders, acoustic trauma, inflammatory disease, psoriasis, arthritis, colitis, aging, viral disease, reproductive disease, and skin conditions or disorders including administering a therapeutically effective amount of the compositions to a subject in need are also provided. The compositions may be topically applied to skin or mucous membranes.

Abstract: This disclosure relates to the engineering of phototrophic microorganisms for conversion of alkanes into higher-value products. Recombinant phototrophic organisms such as cyanobacteria can be engineered, optionally in a modular format, to express enzymes involved in converting methane to methanol, methanol to formaldehyde, formaldehyde to central metabolic pathway intermediates, and such intermediates to n-butanol.

Abstract: Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein. Methods of treating cancer, cardiovascular disease, cardiac failure, diabetes, Alzheimer's disease, Parkinson's disease and other brain diseases, fatty liver disease, obesity, cataracts, osteoporosis, muscle wasting, sleep disorders, acoustic trauma, inflammatory disease, psoriasis, arthritis, colitis, aging, viral disease, reproductive disease, and skin conditions or disorders including administering a therapeutically effective amount of the compositions to a subject in need are also provided. The compositions may be topically applied to skin or mucous membranes.

Abstract: Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein. Methods of treating cancer, cardiovascular disease, cardiac failure, diabetes, Alzheimer's disease, Parkinson's disease and other brain diseases, fatty liver disease, obesity, cataracts, osteoporosis, muscle wasting, sleep disorders, acoustic trauma, inflammatory disease, psoriasis, arthritis, colitis, aging, viral disease, reproductive disease, and skin conditions or disorders including administering a therapeutically effective amount of the compositions to a subject in need are also provided. The compositions may be topically applied to skin or mucous membranes.

Abstract: PEHAM dendrimers of the formula: Specific PEHAM dendrimers are used in a formulation with an active agent for agricultural purposes. In particular, the PEHAM dendrimers may be used for increasing the efficacy of the active agent in various ways, such as by improving solubility of the active agent in the formulation, by improving adhesion and penetration of the active agent to plant surfaces, or by improving the water-fastness of the active agent to the plant or seed. The PEHAM dendrimers may also increase the efficacy of the active agent by increasing soil penetration of the active agent to reach the plant roots or under soil parts, by reducing soil adhesion of the active agent to reach the plant roots or under soil parts, or by reducing enzymatic degradation of the active agent by the plant or seed or microorganisms in the soil.

Abstract: Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein. Methods of treating cancer, cardiovascular disease, cardiac failure, diabetes, Alzheimer's disease, Parkinson's disease and other brain diseases, fatty liver disease, obesity, cataracts, osteoporosis, muscle wasting, sleep disorders, acoustic trauma, inflammatory disease, psoriasis, arthritis, colitis, aging, viral disease, reproductive disease, and skin conditions or disorders including administering a therapeutically effective amount of the compositions to a subject in need are also provided. The compositions may be topically applied to skin or mucous membranes.

Abstract: A system and method for analyzing arrangement of vehicle and building wire harnesses for electromagnetic interference (EMI) are disclosed. In one embodiment, at least design data of a first wire harness and a second wire harness and associated electrical structure of the vehicle or building are received. Further, a plurality of cutting planes are applied to intersect at least the first wire harness and the second wire harness and the associated electrical structure based on the design data. Furthermore, a respective set of cutting points are identified for each of the plurality of cutting planes. The respective set of cutting points includes locations where a respective cutting plane intersects at least the first wire harness and the second wire harness and the associated electrical structure. In addition, a segregation distance is measured between each respective set of cutting points.

Abstract: This disclosure relates to the engineering of phototrophic microorganisms for conversion of alkanes into higher-value products. Recombinant phototrophic organisms such as cyanobacteria can be engineered, optionally in a modular format, to express enzymes involved in converting methane to methanol, methanol to formaldehyde, formaldehyde to central metabolic pathway intermediates, and such intermediates to n-butanol.

Abstract: A method and apparatus are provided for viewing video images. The method includes the steps of an input of a video server receiving indicia identifying an image source providing a sequence of video images of interest and requesting that notification be sent to a user of a wireless electronic device, pushing a notification of the identified source through a persistent connection to the user of a wireless electronic device in response to the request, a user input of the wireless electronic device receiving input accepting the notification and the wireless electronic device automatically launching a viewing application installed on the wireless electronic device in response to the acceptance, the viewing application downloading video images from the image source to the wireless electronic device for viewing.

Abstract: A computer-implemented method for simultaneously providing multiple data protection functions may include identifying a storage appliance that provides a plurality of data protection functions to a production system. The computer-implemented method may also include identifying a splitter channel from the production system to the storage appliance. The computer-implemented method may further include creating a synchronization channel from the production system to the storage appliance. The computer-implemented method may additionally include transmitting changes made to data on the production system to the storage appliance via the splitter channel. The computer-implemented method may also include synchronizing data on the production system to the storage appliance via the synchronization channel. Various other methods, systems, and computer-readable media are also disclosed.

Abstract: A computer-implemented method for managing cluster node connectivity information. The method may include maintaining a set of cluster nodes of a clustered application. The method may also include, for each node in a set of cluster nodes, determining a connectivity state of the cluster node and transmitting, from the cluster node to non-volatile Random Access Memory (“RAM”) of a cluster disk, connectivity information that indicates the connectivity state of the cluster node. The method may further include accessing, from a remote system, the non-volatile RAM of the cluster disk to retrieve connectivity information of one or more cluster nodes from the set of cluster nodes. The method may include using the connectivity information to inform the remote system of the connectivity state of the one or more cluster nodes. Various other methods, systems, and computer-readable media are also disclosed.

Abstract: A computer-implemented method for handling path failures to active-passive storage arrays may include identifying a host system with multiple I/O paths to an active-passive storage array. The computer-implemented method may also include identifying a backup system operating for the host system, the backup system having multiple I/O paths to the active-passive storage array. The computer-implemented method may also include disabling at least one secondary path from the backup system to the active-passive storage array. The computer-implemented method may further include detecting a path failure. The computer-implemented method may additionally include reconfiguring the backup system to access the active-passive storage array through the host system. Various other methods, systems, and computer-readable media are also disclosed.

Abstract: Specific PEHAM dendrimers are used in a formulation with an active agent for agricultural purposes, particularly for increasing the efficacy of the active agent in various ways, such as by improving solubility of the active agent in the formulation, by improving adhesion and penetration of the active agent to plant surfaces, by improving the water-fastness of the active agent to the plant or seed, by increasing soil penetration of the active agent to reach the plant roots or under soil parts, or by reducing soil adhesion of the active agent to reach the plant roots or under soil parts, or reducing enzymatic degradation of the active agent by the plant or seed or microorganisms in the soil.